Strahlentherapie des Mediastinalen Hodgkin-Lymphoms

Literaturverzeichnis
Stuschke, M., Budach, W., and Nüsslin, F. (2009). Praktische Aspekte der Bestrahlungsplanung. In
Radioonkologie, Band 1 Grundlagen, M. Bamberg, M. Molls, and H. Sack, eds. (München Wien New York: W.
Zuckschwerdt Verlag), pp. 153-172.
Sutcliffe, S.B., Wrigley, P.F., Peto, J., Lister, T.A., Stansfeld, A.G., Whitehouse, J.M., Crowther, D., and
Malpas, J.S. (1978). MVPP chemotherapy regimen for advanced Hodgkin's disease. Br Med J 1, 679-683.
Swerdlow, A.J., Barber, J.A., Hudson, G.V., Cunningham, D., Gupta, R.K., Hancock, B.W., Horwich, A., Lister,
T.A., and Linch, D.C. (2000). Risk of second malignancy after Hodgkin's disease in a collaborative British
cohort: the relation to age at treatment. J Clin Oncol 18, 498-509.
Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., and Thiele, J. (2008). IARC WHO
Classification of Tumours of Haematopoietic and Lymphoid Tissues. In WHO Classification of Tumours
Volume 2 (Lyon: IARC).
Tesch, H., Diehl, V., Lathan, B., Hasenclever, D., Sieber, M., Ruffer, U., Engert, A., Franklin, J., Pfreundschuh,
M., Schalk, K.P., Schwieder, G., Wulf, G., Dolken, G., Worst, P., Koch, P., Schmitz, N., Bruntsch, U., Tirier, C.,
Muller, U., and Loeffler, M. (1998). Moderate dose escalation for advanced stage Hodgkin's disease using the
bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and
adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group. Blood 92, 4560-4567.
Traverse-Glehen, A., Pittaluga, S., Gaulard, P., Sorbara, L., Alonso, M.A., Raffeld, M., and Jaffe, E.S. (2005).
Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large
B-cell lymphoma. Am J Surg Pathol 29, 1411-1421.
Travis, L.B. (2006). The epidemiology of second primary cancers. Cancer Epidemiol Biomarkers Prev 15, 2020-
2026.
Travis, L.B., Gospodarowicz, M., Curtis, R.E., Clarke, E.A., Andersson, M., Glimelius, B., Joensuu, T., Lynch,
C.F., van Leeuwen, F.E., Holowaty, E., Storm, H., Glimelius, I., Pukkala, E., Stovall, M., Fraumeni, J.F., Jr.,
Boice, J.D., Jr., and Gilbert, E. (2002). Lung cancer following chemotherapy and radiotherapy for Hodgkin's
disease. J Natl Cancer Inst 94, 182-192.
Travis, L.B., Hill, D., Dores, G.M., Gospodarowicz, M., van Leeuwen, F.E., Holowaty, E., Glimelius, B.,
Andersson, M., Pukkala, E., Lynch, C.F., Pee, D., Smith, S.A., Van't Veer, M.B., Joensuu, T., Storm, H., Stovall,
M., Boice, J.D., Jr., Gilbert, E., and Gail, M.H. (2005). Cumulative absolute breast cancer risk for young women
treated for Hodgkin lymphoma. J Natl Cancer Inst 97, 1428-1437.
Travis, L.B.M.D., Hill, D.A.P., Dores, G.M.M.D., Gospodarowicz, M.M.D., van Leeuwen, F.E.P., Holowaty,
E.M.D., Glimelius, B.M.D., Andersson, M.M.D., Wiklund, T.M.D., Lynch, C.F.M.D., Van't Veer, M.B.M.D.,
Glimelius, I.M.D., Storm, H.M.D., Pukkala, E.P., Stovall, M.P., Curtis, R.M.A., Boice, J.D.J.S., and Gilbert,
E.P. (2003). Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin
Disease. JAMA 290, 465-475.
Urba, W.J., and Longo, D.L. (1993). Hodgkin's disease in adults. Part I. Invest Radiol 28, 737-752.
van den Belt-Dusebout, A.W., Aleman, B.M.P., Besseling, G., de Bruin, M.L., Hauptmann, M., van 't Veer,
M.B., de Wit, R., Ribot, J.G., Noordijk, E.M., Kerst, J.M., Gietema, J.A., and van Leeuwen, F.E. (2009). Roles
of Radiation Dose and Chemotherapy in the Etiology of Stomach Cancer as a Second Malignancy. Int J Radiat
Oncol Biol Phys 75, 1420-1429.
van Leeuwen, F.E., Chorus, A.M., van den Belt-Dusebout, A.W., Hagenbeek, A., Noyon, R., van Kerkhoff,
E.H., Pinedo, H.M., and Somers, R. (1994). Leukemia risk following Hodgkin's disease: relation to cumulative
dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and
bone marrow damage. J Clin Oncol 12, 1063-1073.
van Leeuwen, F.E., Klokman, W.J., Stovall, M., Dahler, E.C., van't Veer, M.B., Noordijk, E.M., Crommelin,
M.A., Aleman, B.M., Broeks, A., Gospodarowicz, M., Travis, L.B., and Russell, N.S. (2003). Roles of radiation
dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 95,
971-980.
van Leeuwen, F.E., Klokman, W.J., Stovall, M., Hagenbeek, A., van den Belt-Dusebout, A.W., Noyon, R.,
Boice, J.D., Jr., Burgers, J.M., and Somers, R. (1995). Roles of radiotherapy and smoking in lung cancer
following Hodgkin's disease. J Natl Cancer Inst 87, 1530-1537.
van Leeuwen, F.E., Klokman, W.J., Veer, M.B., Hagenbeek, A., Krol, A.D., Vetter, U.A., Schaapveld, M., van
Heerde, P., Burgers, J.M., Somers, R., and Aleman, B.M. (2000). Long-term risk of second malignancy in
survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18, 487-497.
134